CURAM Powder for oral suspension / Film-coated tablet Ref.[50585] Active ingredients: Amoxicillin Clavulanic acid

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2022  Publisher: Novartis New Zealand Limited, PO Box 99102, Newmarket, Auckland 1149 Telephone: 0800 354 335

Product name and form

Curam Powder for oral suspension.

Curam Film coated tablet.

Curam Duo 500/125 Film coated tablet.

Pharmaceutical Form

Curam tablet: Tablet, film-coated, oblong biconvex formed, off-white colour, scored on both sides.

Curam Duo 500/125 tablet: Tablet, film-coated, oval biconvex formed, off-white colour, scored on both sides.

Curam powder for oral suspension: Suspension, oral, powder for, white to yellowish colour.

Qualitative and quantitative composition

Curam tablet

250 + 125 mg: Each tablet contains Amoxicillin Trihydrate Ph. Eur. equivalent to amoxicillin 250 mg and Potassium Clavulanate Ph. Eur. equivalent to clavulanic acid 125 mg.

Curam Duo 500/125 tablet

500 + 125 mg: Each tablet contains Amoxicillin Trihydrate Ph. Eur. equivalent to amoxicillin 500 mg and Potassium Clavulanate Ph. Eur. equivalent to clavulanic acid 125 mg.

Curam powder for oral suspension

125 + 31.25 mg/5 mL: Reconstituted suspension contains in 5 mL, Amoxicillin Trihydrate Ph. Eur. equivalent to amoxicillin 125 mg and Potassium Clavulanate Ph. Eur. equivalent to clavulanic acid 31.25 mg.

250 + 62.5 mg/5 mL: Reconstituted suspension contains in 5 mL, Amoxicillin Trihydrate Ph. Eur. equivalent to amoxicillin 250 mg and Potassium Clavulanate Ph. Eur. equivalent to clavulanic acid 62.5 mg.

List of excipients with known effect: Aspartame.

For the full list of excipients, see Section 6.1 List of excipients.

Active Ingredient Description
Amoxicillin

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

Clavulanic acid

Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.

List of Excipients

Curam tablet:

Microcrystalline cellulose, croscarmellose sodium, talc, povidone, magnesium stearate, titanium dioxide, hypromellose, ethylcellulose, sodium lauryl sulfate, cetyl alcohol, triethyl citrate.

Curam powder for oral suspension:

Colloidal silicon dioxide, guar gum, aspartame, talc, trisodium citrate, citric acid, orange flavour, lemon flavour, peach-apricot flavour.

These medicines do not contain lactose or gluten.

Pack sizes and marketing

Curam tablet: Blisters of 15, 21 and 100 tablets.

Curam Duo 500/125 tablet: Blisters of 10, 15, 21, 50, 80 and 100 tablets.

Curam powder for oral suspension: Bottles of 60 and 100 mL with a 5 mL dosing syringe.

All presentations, strengths or pack sizes may not be currently marketed.

Marketing authorization holder

Novartis New Zealand Limited, PO Box 99102, Newmarket, Auckland 1149
Telephone: 0800 354 335

Marketing authorization dates and numbers

Date of first approval: 21 August 2016

Drugs

Drug Countries
CURAM Austria, Australia, Ecuador, Hong Kong, New Zealand, Singapore, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.